Table 4 |
||
|
Stratified analyses for the evaluation of heterogeneity in studies with in-house tests |
||
|
Subgroup |
Summary Diagnostic Odds Ratio (95% CI)a |
Test for heterogeneityb p value |
|
|
||
|
Study design |
||
|
Case-control (N = 12 studies) |
68.3 (31.8, 146.5) |
0.39 |
|
Cross-sectional (N = 14 studies) |
28.7 (12.3, 66.9) |
0.002 |
|
Target sequence |
||
|
IS6110 (N = 12 studies) |
62.4 (32.8, 118.7) |
0.42 |
|
Other target sequences (N = 14 studies) |
25.5 (10.6, 61.3) |
0.006 |
|
|
||
|
aConfidence interval bChi-square test for heterogeneity |
||
|
Pai et al. BMC Infectious Diseases 2004 4:6 doi:10.1186/1471-2334-4-6 |
||
